These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26956793)

  • 1. Pairwise antibiotic interactions in Escherichia coli: triclosan, rifampicin and aztreonam with nine other classes of antibiotics.
    Nguyen C; Zhou A; Khan A; Miller JH; Yeh P
    J Antibiot (Tokyo); 2016 Nov; 69(11):791-797. PubMed ID: 26956793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
    Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Escherichia coli NDM isolates with decreased susceptibility to aztreonam/avibactam: role of a novel insertion in PBP3.
    Alm RA; Johnstone MR; Lahiri SD
    J Antimicrob Chemother; 2015 May; 70(5):1420-8. PubMed ID: 25634992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic variation in susceptibility and metabolism of triclosan-resistant mutants of Escherichia coli and Klebsiella pneumoniae clinical strains obtained after exposure to biocides and antibiotics.
    Curiao T; Marchi E; Viti C; Oggioni MR; Baquero F; Martinez JL; Coque TM
    Antimicrob Agents Chemother; 2015; 59(6):3413-23. PubMed ID: 25824225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low level of cross-resistance between triclosan and antibiotics in Escherichia coli K-12 and E. coli O55 compared to E. coli O157.
    Braoudaki M; Hilton AC
    FEMS Microbiol Lett; 2004 Jun; 235(2):305-9. PubMed ID: 15183878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [In vitro combined effects of double antibacterial drugs against multidrug-resistant Pseudomonas aeruginosa isolates: comparison among combinations of colistin, arbekacin, aztreonam, rifampicin and piperacillin].
    Nagaoka R; Ikawa K; Onodera M; Koba Y; Hara T; Joichi Y; Yokozaki M; Ohge H; Morikawa N
    Jpn J Antibiot; 2014 Jun; 67(3):167-74. PubMed ID: 25163250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triclosan-tolerant bacteria: changes in susceptibility to antibiotics.
    Cottell A; Denyer SP; Hanlon GW; Ochs D; Maillard JY
    J Hosp Infect; 2009 May; 72(1):71-6. PubMed ID: 19246121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases.
    Papp-Wallace KM; Bajaksouzian S; Abdelhamed AM; Foster AN; Winkler ML; Gatta JA; Nichols WW; Testa R; Bonomo RA; Jacobs MR
    Diagn Microbiol Infect Dis; 2015 May; 82(1):65-9. PubMed ID: 25737290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell elongation and septation are two mutually exclusive processes in Escherichia coli.
    Canepari P; Signoretto C; Boaretti M; Lleò MM
    Arch Microbiol; 1997 Aug; 168(2):152-9. PubMed ID: 9238107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular activity of cefamandole and aztreonam against phagocytosed Escherichia coli and Staphylococcus aureus.
    Adinolfi LE; Utili R; Dilillo M; Tripodi MF; Attanasio V; Ruggiero G
    J Antimicrob Chemother; 1989 Dec; 24(6):927-35. PubMed ID: 2695512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents.
    Mishra S; Karmodiya K; Parasuraman P; Surolia A; Surolia N
    Bioorg Med Chem; 2008 May; 16(10):5536-46. PubMed ID: 18434169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of the post-antibiotic effects induced by rifampicin and gentamicin in Escherichia coli.
    Stubbings W; Bostock J; Ingham E; Chopra I
    J Antimicrob Chemother; 2006 Aug; 58(2):444-8. PubMed ID: 16735423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in antibacterial activity of triclosan and sulfa drugs due to photochemical transformations.
    Wammer KH; Lapara TM; McNeill K; Arnold WA; Swackhamer DL
    Environ Toxicol Chem; 2006 Jun; 25(6):1480-6. PubMed ID: 16764465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of antimicrobial activity through sustained release of triclosan from pegylated silicone elastomers.
    McBride MC; Karl Malcolm R; David Woolfson A; Gorman SP
    Biomaterials; 2009 Dec; 30(35):6739-47. PubMed ID: 19765822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide enrichment screening reveals multiple targets and resistance genes for triclosan in Escherichia coli.
    Yu BJ; Kim JA; Ju HM; Choi SK; Hwang SJ; Park S; Kim E; Pan JG
    J Microbiol; 2012 Oct; 50(5):785-91. PubMed ID: 23124746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monobactam antibiotics in subinhibitory concentrations enhance opsonophagocytosis and serum bacteriolysis in certain Escherichia coli strains.
    Veringa E; Box A; Rozenberg-Arska M; Verhoef J
    Drugs Exp Clin Res; 1988; 14(1):1-8. PubMed ID: 3292179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro antimicrobial activity of a novel aminothiazolylglycylcephalosporin, MT0703S, compared with that of ceftazidime, cefoperazone and aztreonam.
    Okamoto R; Hara T; Yoshida T; Orikasa Y; Ogino H; Iwamatsu K; Inouye S
    Drugs Exp Clin Res; 1990; 16(4):157-65. PubMed ID: 2127567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of aztreonam and other antimicrobial agents against Salmonella species.
    Paradelis AG; Delidou K; Stavrakis AO; Crassaris LG
    Drugs Exp Clin Res; 1985; 11(3):163-7. PubMed ID: 3836124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential modulation of the induction of inflammatory mediators by antibiotics in mouse macrophages in response to viable Gram-positive and Gram-negative bacteria.
    Cui W; Lei MG; Silverstein R; Morrison DC
    J Endotoxin Res; 2003; 9(4):225-36. PubMed ID: 12935353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of triclosan on uropathogen susceptibility to clinically relevant antibiotics.
    Wignall GR; Goneau LW; Chew BH; Denstedt JD; Cadieux PA
    J Endourol; 2008 Oct; 22(10):2349-56. PubMed ID: 18937596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.